Geneva, Oct. 27 -- International Clinical Trials Registry received information related to the study (ISRCTN18140237) titled 'Evaluation of a scalp serum to help reduce hair loss and improve scalp health' on Oct. 16.
Study Type: Interventional
Study Design:
Allocation: Randomized controlled trial
Masking: Blinded (masking used)
Control: Placebo
Assignment: Parallel
Purpose: Treatment
Primary Sponsor: Shenzhen Hujia Technology Co., Ltd.
Condition:
Hair loss (self-perceived excessive hair shedding and mild hair thinning in healthy adults)
Skin and Connective Tissue Diseases
Intervention:
Seventy eligible Chinese subjects will be recruited to guarantee a minimum of 30 valid completers per group. Participants are stratified-randomised...